Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP772281.RAtGLFXTDBP94sGIYfOL8NFYVz4lnXT_RRYNjAMABzATM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP772281.RAtGLFXTDBP94sGIYfOL8NFYVz4lnXT_RRYNjAMABzATM130_assertion type Assertion NP772281.RAtGLFXTDBP94sGIYfOL8NFYVz4lnXT_RRYNjAMABzATM130_head.
- NP772281.RAtGLFXTDBP94sGIYfOL8NFYVz4lnXT_RRYNjAMABzATM130_assertion wasGeneratedBy ECO_0000203 NP772281.RAtGLFXTDBP94sGIYfOL8NFYVz4lnXT_RRYNjAMABzATM130_provenance.
- NP772281.RAtGLFXTDBP94sGIYfOL8NFYVz4lnXT_RRYNjAMABzATM130_assertion wasDerivedFrom befree-2016 NP772281.RAtGLFXTDBP94sGIYfOL8NFYVz4lnXT_RRYNjAMABzATM130_provenance.
- NP772281.RAtGLFXTDBP94sGIYfOL8NFYVz4lnXT_RRYNjAMABzATM130_assertion SIO_000772 19864236 NP772281.RAtGLFXTDBP94sGIYfOL8NFYVz4lnXT_RRYNjAMABzATM130_provenance.
- NP772281.RAtGLFXTDBP94sGIYfOL8NFYVz4lnXT_RRYNjAMABzATM130_assertion evidence source_evidence_literature NP772281.RAtGLFXTDBP94sGIYfOL8NFYVz4lnXT_RRYNjAMABzATM130_provenance.
- NP772281.RAtGLFXTDBP94sGIYfOL8NFYVz4lnXT_RRYNjAMABzATM130_assertion description "[Our results from a large series of Chinese patients with breast cancer support that the ASCO/CAP 30% criterion may offer better results for assessing HER2 status.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP772281.RAtGLFXTDBP94sGIYfOL8NFYVz4lnXT_RRYNjAMABzATM130_provenance.